Clinical Proof-of-Concept Study With MSDC-0160, a Prototype mTOT-Modulating Insulin Sensitizer.
Colca, J R; VanderLugt, J T; Adams, W J; Shashlo, A; McDonald, W G; Liang, J; Zhou, R; Orloff, D G; Clinical Pharmacology & Therapeutics, 2013, vol. 93, issue 4, p 352, ISSN 00099236. ISBN 15326535.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef